Catalyst Wire Dossier Catalyst Wire Dossier

Atropine 0.01% ophthalmic solution

atropine · Eyenovia Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Atropine 0.01% ophthalmic solution, covering 2025-01-06 to 2025-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control [NA]

See pricing